TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

8611	Companies
141742	Keywords
77650	Articles
75757	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 09/14/2024 at 09:05, 6 months 29 days ago

Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration

Transgene Oncolytic Virus BioInvent Antitumor Activity ESMO 2024
BRIEF

published on 09/13/2024 at 10:37, 7 months ago

Franchissement de seuil par SITAM Belgique dans TRANSGENE S.A.

Droits De Vote Franchissement De Seuil Augmentation De Capital SITAM Belgique TRANSGENE S.A.
BRIEF

published on 09/13/2024 at 10:37, 7 months ago

Threshold crossing by SITAM Belgium in TRANSGENE SA

Voting Rights Capital Increase Threshold Crossing SITAM Belgium TRANSGENE SA
PRESS RELEASE

published on 09/13/2024 at 10:32, 7 months ago

Franchissement de seuil
Déclaration de franchissement de seuil de la société TRANSGENE S.A. par SITAM Belgique, détenant 3,65% du capital et 4,85% des droits de vote

Déclaration Franchissement De Seuil AMF SITAM Belgique TRANSGENE S.A.
BRIEF

published on 09/10/2024 at 07:35, 7 months 3 days ago

Transgene nomme deux leaders chevronnés en oncologie pour piloter sa prochaine phase d'innovation

Immunothérapie Direction Oncologie Traitement Du Cancer Transgene
BRIEF

published on 09/10/2024 at 07:35, 7 months 3 days ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation

Cancer Treatment Oncology Leadership Immunotherapy Transgene
PRESS RELEASE

published on 09/10/2024 at 07:30, 7 months 3 days ago

Transgene Appoints Two Seasoned Leaders in Oncology to Drive its Next Phase of Innovation
Transgene appoints Dr. Emmanuelle Dochy as CMO and Dr. Maurizio Ceppi as CSO to drive innovation in cancer immunotherapies. Company progresses clinical pipeline with therapeutic vaccine TG4050

Innovation Oncology Clinical Pipeline Immunotherapy Transgene
BRIEF

published on 08/27/2024 at 07:35, 7 months 17 days ago

Transgene publie des données précliniques sur le virus oncolytique TG6050 au JITC

Transgene Données Précliniques TG6050 JITC Virus Oncolytique
BRIEF

published on 08/27/2024 at 07:35, 7 months 17 days ago

Transgene Publishes Preclinical Data on Oncolytic Virus TG6050 in JITC

Preclinical Data Transgene Oncolytic Virus TG6050 JITC
PRESS RELEASE

published on 08/27/2024 at 07:30, 7 months 17 days ago

Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC

Phase I Trial Transgene Oncolytic Virus TG6050 JITC Publication

Accesswire

Published on 04/12/2025 at 15:45, 22 hours 57 minutes ago

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 12 hours ago

Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 14 hours ago

Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/12/2025 at 00:00, 1 day 14 hours ago

Ur-Energy Releases 2024 Year End Results
Published on 04/11/2025 at 23:45, 1 day 14 hours ago

Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 21:45, 1 day 16 hours ago

OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:40, 1 day 20 hours ago

AGM 2025 - Bossard Holding AG Press Release
Published on 04/11/2025 at 18:38, 1 day 20 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 20 hours ago

EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:10, 1 day 20 hours ago

Kaufman & Broad SA: 2025, 1ST QUARTER RESULTS

Les Echos

Published on 04/11/2025 at 18:30, 1 day 20 hours ago

Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 20 hours ago

Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 20 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 20 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 20 hours ago

Mise à disposition du Rapport Financier Annuel 2024

View all LES ECHOS COMFI WIRE